| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.024 | 0.8 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.026 | 0.8 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |